{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:55:06Z","timestamp":1784051706915,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2018.01.051","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:54:37Z","timestamp":1519127677000},"page":"422-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4"],"prefix":"10.1016","volume":"99","author":[{"given":"Yan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.01.051_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.051_bib0010","first-page":"287","article-title":"Popular misconceptions regarding the diabetes management: where should we focus our attention?","volume":"7","author":"Patil","year":"2013","journal-title":"J. Clin. Diagn. Res. JCDR"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.051_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.krcp.2014.08.001","article-title":"Comprehensive approach to diabetic nephropathy","volume":"33","author":"Satirapoj","year":"2014","journal-title":"Kidney Res. Clin. Prac."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.051_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jarr.2001.21711","article-title":"Diabetic nephropathy and end-stage renal failure: the Norwegian story","volume":"8","author":"Bergrem","year":"2001","journal-title":"Adv. Ren. Replace Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.051_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-6386(00)70316-7","article-title":"Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia\/New Zealand: results from an international comparative study","volume":"35","author":"Maisonneuve","year":"2000","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.051_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dom.12630","article-title":"Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?","volume":"18","author":"Gallagher","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"1 Suppl. 1","key":"10.1016\/j.biopha.2018.01.051_bib0035","article-title":"United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.051_bib0040","first-page":"444","article-title":"The pathogenesis of diabetic nephropathy, nature clinical practice","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.051_bib0045","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1073\/pnas.122228799","article-title":"3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho gtpase\/ p21 signaling pathway: implications for diabetic nephropathy","volume":"99","author":"Danesh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.051_bib0050","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00266.2015","article-title":"Twenty years after aceis and arbs: emerging treatment strategies for diabetic nephropathy","volume":"309","author":"Johnson","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.051_bib0055","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1097\/01.ASN.0000146423.71226.0C","article-title":"Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results","volume":"15","author":"Remuzzi","year":"2004","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.051_bib0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3835(98)00081-0","article-title":"Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice","volume":"129","author":"Park","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.01.051_bib0065","first-page":"229","article-title":"Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite","volume":"38","author":"Sies","year":"1997","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"issue":"6","key":"10.1016\/j.biopha.2018.01.051_bib0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.exger.2010.03.005","article-title":"Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway","volume":"45","author":"Kim","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.051_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbt.21668","article-title":"Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats","volume":"29","author":"Hemalatha","year":"2015","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.051_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11064-005-2606-3","article-title":"Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum","volume":"30","author":"Kabuto","year":"2005","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.051_bib0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jmf.2007.0660","article-title":"Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats","volume":"12","author":"Chung","year":"2009","journal-title":"J. Med. Food"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.01.051_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mrgentox.2009.05.004","article-title":"Radiomodifying and anticlastogenic effect of zingerone on swiss albino mice exposed to whole body gamma radiation","volume":"677","author":"Rao","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2018.01.051_bib0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2015.12.027","article-title":"Zingerone ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting toll-like receptor 4 signaling pathway","volume":"772","author":"Song","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.051_bib0100","article-title":"Nephro protective effect of zingerone against ccl4 induced renal toxicity in swiss albino mice; molecular mechanism","author":"Safhi","year":"2017","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.051_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000443433","article-title":"Chronic administration of visfatin ameliorated diabetic nephropathy in type 2 diabetic mice","volume":"41","author":"Kang","year":"2016","journal-title":"Kidney Blood Pressure Res."},{"key":"10.1016\/j.biopha.2018.01.051_bib0110","doi-asserted-by":"crossref","first-page":"806358","DOI":"10.1155\/2015\/806358","article-title":"Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease","volume":"2015","author":"Tucker","year":"2015","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"9","key":"10.1016\/j.biopha.2018.01.051_bib0115","doi-asserted-by":"crossref","first-page":"e75547","DOI":"10.1371\/journal.pone.0075547","article-title":"Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria","volume":"8","author":"Tobar","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.biopha.2018.01.051_bib0120","doi-asserted-by":"crossref","first-page":"44492","DOI":"10.1038\/srep44492","article-title":"Carnosine attenuates the development of both type 2 diabetes and diabetic nephropathy in BTBR ob\/ob mice","volume":"7","author":"Albrecht","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.051_bib0125","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/db08-0061","article-title":"From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy","volume":"57","author":"Qian","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.biopha.2018.01.051_bib0130","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","article-title":"Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by toll-like receptor 4 in mice","volume":"55","author":"Kuwabara","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.051_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci. (London, Engl. 1979)"},{"issue":"5","key":"10.1016\/j.biopha.2018.01.051_bib0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2174\/1389450115666140321120635","article-title":"Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy","volume":"15","author":"Arora","year":"2014","journal-title":"Curr. Drug Targets"},{"issue":"12","key":"10.1016\/j.biopha.2018.01.051_bib0145","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.2337\/db10-0195","article-title":"Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E\/GPx1-double knockout mouse","volume":"59","author":"Chew","year":"2010","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2018.01.051_bib0150","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/01.ASN.0000135971.88164.2C","article-title":"Nephropathy in zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen","volume":"15","author":"Chander","year":"2004","journal-title":"J. Am. Soc. Nephrol. JASN"},{"issue":"Suppl 11","key":"10.1016\/j.biopha.2018.01.051_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ndt\/17.suppl_11.23","article-title":"The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease","volume":"17","author":"Krane","year":"2002","journal-title":"Nephrol. Dialysis Transplant."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.051_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00125-015-3796-0","article-title":"Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy","volume":"59","author":"Jha","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.biopha.2018.01.051_bib0165","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00396.2014","article-title":"Targeting NADPH oxidase with a novel dual Nox1\/Nox4 inhibitor attenuates renal pathology in type 1 diabetes","volume":"308","author":"Gorin","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.051_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jnutbio.2014.03.010","article-title":"Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4\/TGFbeta-1 signaling","volume":"25","author":"Papadimitriou","year":"2014","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.051_bib0175","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1681\/ASN.2013070810","article-title":"Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy","volume":"25","author":"Jha","year":"2014","journal-title":"J. Am. Soc. Nephrol. JASN"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:26:30Z","timestamp":1781591190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217360018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":35,"alternative-id":["S0753332217360018"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.051","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}